Skip to main content

Understanding Quality Control Materials in Clinical Laboratories

Multichem®: Consolidated quality control for modern laboratories

Many clinical laboratories operate multiple analysers while supporting increasingly diverse test menus. Maintaining separate controls for every discipline can increase inventory requirements, staff workload and administrative burden.

We developed Multichem® quality control materials to simplify this challenge through a consolidated QC approach. Selected Multichem® products provide broad analyte coverage, enabling laboratories to consolidate quality control across chemistry and immunoassay workflows while reducing inventory complexity and simplifying routine QC review.

Key features include:

  • Independent third-party controls
  • Liquid-stable, ready-to-use formats
  • Assayed target values
  • Tri-level control options
  • Broad analyte coverage
  • Compatibility with multiple analyser platforms
  • Open-vial and closed-vial stability designed to reduce waste
  • Support for peer-group comparison and QC informatics programmes

For laboratories seeking to standardise quality control processes, a consolidated approach can reduce complexity while maintaining robust oversight of analytical performance.

Choosing a quality control material by test menu

  • Clinical Chemistry: Broad multi-analyte controls help laboratories monitor routine chemistry assays while reducing the number of products required for daily QC review.

  • Immunoassay: Independent controls help assess assay consistency over time and may assist in identifying shifts associated with reagent lot changes or calibration events.

  • Toxicology: Multi-level controls support performance monitoring across clinically relevant concentration ranges and contribute to confidence in reportable range verification.

  • Core Laboratory Operations: Consolidated QC materials can help standardise quality procedures across disciplines, simplify inventory management and reduce administrative workload.

Third-party controls vs in-kit controls: Why independence matters

Manufacturer-supplied controls can be useful for verifying routine system performance, but they may not always detect issues originating within the same testing ecosystem. Third-party controls provide an independent measure of assay performance and can help laboratories identify calibration shifts, reagent lot variability and instrument-related issues sooner. This additional layer of oversight is particularly valuable when investigating unexpected QC events or assessing long-term assay stability.

Assayed vs unassayed quality control materials

Assayed controls include assigned target values for specific analytes and are often used when laboratories require straightforward implementation and peer-group comparison. Unassayed controls provide greater flexibility, allowing laboratories to establish their own means and control limits based on local performance data. The most appropriate choice depends on quality objectives, accreditation requirements and laboratory workflows.

Open-vial and closed-vial stability

Control stability can have a significant impact on laboratory efficiency and cost management. Products with extended open-vial stability may reduce waste and improve utilisation, particularly in lower-volume laboratories. Closed-vial stability supports inventory planning by allowing laboratories to maintain stock without unnecessary replacement.

Test consolidation across multiple analysers

As testing menus expand, managing multiple quality control products becomes increasingly complex. Consolidated controls help laboratories standardise QC practices across analysers and disciplines while reducing inventory requirements, simplifying procurement and streamlining routine review processes.

QC informatics, Westgard rules and peer-group monitoring

Modern laboratories increasingly rely on QC informatics platforms to review performance data, monitor trends and support standardised decision-making. When combined with independent third-party controls, Westgard multi-rule analysis, Levey-Jennings charting and peer-group comparison can help laboratories identify emerging performance issues earlier and respond before patient testing is affected.